This inventor holds 6 USPTO granted patents and 6 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Absolutely! Here is the article about inventor Zhixiang Zheng:
Title: Innovator Spotlight: Zhixiang Zheng, Pioneering Inventor at Merck Sharp & Dohme Corporation
Introduction:
Zhixiang Zheng, a distinguished inventor based in Beijing, CN, has made substantial contributions to the field of pharmaceuticals with his groundbreaking patents. With a total of 6 patents to his name, Zheng is renowned for his innovative work in developing metallo-β-lactamase inhibitors and Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors.
Latest Patents:
1. Metallo-β-lactamase inhibitors: Zheng's inventive compounds of Formula I have shown promise in combating antibiotic resistance. These inhibitors, in combination with beta-lactam antibiotics and beta-lactamase inhibitor compounds, offer new avenues for treating bacterial infections effectively.
2. Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors: Zheng's novel compounds of Formula (I) serve as potent JAK inhibitors, holding immense potential in treating various JAK-mediated diseases like rheumatoid arthritis, asthma, COPD, and cancer.
Career Highlights:
Currently affiliated with Merck Sharp & Dohme Corporation, Zheng continues to push the boundaries of pharmaceutical research and development. His relentless pursuit of innovation has positioned him as a key player in the industry, driving advancements in drug discovery and treatment strategies.
Collaborations:
Working alongside esteemed colleagues like Yunfeng Bai and Peter H Fuller, Zheng has fostered a collaborative environment at Merck Sharp & Dohme Corporation. Together, they aim to address complex healthcare challenges and bring transformative solutions to the market.
Conclusion:
Inventor Zhixiang Zheng's trailblazing work in the pharmaceutical sector underscores his commitment to driving positive change in healthcare. With a focus on developing cutting-edge treatments for antibiotic-resistant infections and JAK-mediated diseases, Zheng's patents stand as a testament to his ingenuity and dedication to improving patient outcomes.
Is there anything else you would like to know about Zhixiang Zheng or any other innovative inventors?
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile